Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolus (EOLS) Cash & Equivalents (2018 - 2025)

Evolus' Cash & Equivalents history spans 8 years, with the latest figure at $53.8 million for Q4 2025.

  • For Q4 2025, Cash & Equivalents fell 38.1% year-over-year to $53.8 million; the TTM value through Dec 2025 reached $53.8 million, down 38.1%, while the annual FY2025 figure was $53.8 million, 38.1% down from the prior year.
  • Cash & Equivalents reached $53.8 million in Q4 2025 per EOLS's latest filing, up from $43.5 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $146.3 million in Q4 2021 to a low of $22.2 million in Q1 2021.
  • Average Cash & Equivalents over 5 years is $74.1 million, with a median of $66.7 million recorded in 2022.
  • Peak YoY movement for Cash & Equivalents: surged 381.13% in 2022, then crashed 70.5% in 2023.
  • A 5-year view of Cash & Equivalents shows it stood at $146.3 million in 2021, then crashed by 63.13% to $53.9 million in 2022, then grew by 16.53% to $62.8 million in 2023, then skyrocketed by 38.37% to $87.0 million in 2024, then crashed by 38.1% to $53.8 million in 2025.
  • Per Business Quant, the three most recent readings for EOLS's Cash & Equivalents are $53.8 million (Q4 2025), $43.5 million (Q3 2025), and $61.7 million (Q2 2025).